timolol has been researched along with spiraprilat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cinotti, AA; Constad, WH; Fiore, P; Samson, C | 1 |
| Ahn, HS; Barnett, A; Baum, T; Cedeno, K; Smith, EM; Watkins, RW; Yuen, PH | 1 |
1 trial(s) available for timolol and spiraprilat
| Article | Year |
|---|---|
Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Phenylbutyrates; Pulse; Spiro Compounds; Time Factors; Timolol | 1988 |
1 other study(ies) available for timolol and spiraprilat
| Article | Year |
|---|---|
Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits.
Topics: Administration, Topical; Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Consciousness; Intraocular Pressure; Male; Phenylbutyrates; Rabbits; Spiro Compounds; Time Factors; Timolol | 1987 |